Aroni K, Tsagroni E, Kavantzas N, Patsouris E, Ioannidis E (2008) A study of the pathogenesis of rosacea: how angiogenesis and mast cells may participate in a complex multifactorial process. Arch Dermatol Res 300:125–131

Article  PubMed  Google Scholar 

Ashina K, Tsubosaka Y, Nakamura T, Omori K, Kobayashi K, Hori M, Ozaki H, Murata T (2015) Histamine induces vascular hyperpermeability by increasing blood flow and endothelial barrier disruption in vivo. PLoS ONE 10:e0132367

Article  PubMed  PubMed Central  Google Scholar 

Augustin M, Herberger K, Hintzen S, Heigel H, Franzke N, SCHäFER, I. (2011) Prevalence of skin lesions and need for treatment in a cohort of 90 880 workers. Br J Dermatol 165:865–873

Article  CAS  PubMed  Google Scholar 

Baldwin H, Alexis A, Andriessen A, Berson D, Harper J, Lain E, Marchbein S, Stein Gold L (2022) Supplement article: skin barrier deficiency in Rosacea: an algorithm integrating OTC skincare products into treatment regimens. J Drugs Dermatol 21:3595563–35955610

Google Scholar 

Brown TT, Choi EY, Thomas DG, Hristov AC, Chan MP (2014) Comparative analysis of rosacea and cutaneous lupus erythematosus: histopathologic features, T-cell subsets, and plasmacytoid dendritic cells. J Am Acad Dermatol 71:100–107

Article  CAS  PubMed  Google Scholar 

Buhl T, Sulk M, Nowak P, Buddenkotte J, Mcdonald I, Aubert J, Carlavan I, Déret S, Reiniche P, Rivier M, Voegel JJ, Steinhoff M (2015) Molecular and Morphological Characterization of Inflammatory Infiltrate in Rosacea Reveals Activation of Th1/Th17 Pathways. J Invest Dermatol 135:2198–2208

Article  CAS  PubMed  Google Scholar 

Cardamone C, Parente R, Feo GD, Triggiani M (2016) Mast cells as effector cells of innate immunity and regulators of adaptive immunity. Immunol Lett 178:10–14

Article  CAS  PubMed  Google Scholar 

Choi JE, di Nardo A (2018) Skin neurogenic inflammation. Semin Immunopathol 40:249–259

Article  PubMed  PubMed Central  Google Scholar 

Choi JE, Werbel T, Wang Z, Wu CC, Yaksh TL, di Nardo A (2019) Botulinum toxin blocks mast cells and prevents rosacea like inflammation. J Dermatol Sci 93:58–64

Article  CAS  PubMed  Google Scholar 

Choudhary MI, Jalil S, Nawaz SA, Khan KM, Tareen RB (2009) Antiinflammatory and lipoxygenase inhibitory compounds from Vitex agnus-castus. Phytother Res 23:1336–1339

Article  CAS  PubMed  Google Scholar 

Clanner-Engelshofen BM, Bernhard D, Dargatz S, Flaig MJ, Gieler U, Kinberger M, Klövekorn W, Kuna AC, Läuchli S, Lehmann P, Nast A, Pleyer U, Schaller M, Schöfer H, Steinhoff M, Schwennesen T, Werner RN, Zierhut M, Reinholz M (2022) S2k guideline: Rosacea. J Dtsch Dermatol Ges 20:1147–1165

Article  PubMed  Google Scholar 

Deng Z, Chen M, Liu Y, Xu S, Ouyang Y, Shi W, Jian D, Wang B, Liu F, Li J, Shi Q, Peng Q, Sha K, Xiao W, Liu T, Zhang Y, Zhang H, Wang Q, Sun L, Xie H, Li J (2021) A positive feedback loop between mTORC1 and cathelicidin promotes skin inflammation in rosacea. EMBO Mol Med 13:e13560

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ebeigbe AB, Talabi OO (2014) Vascular Effects of Histamine. Niger J Physiol Sci 29:7–10

PubMed  Google Scholar 

Fisher GW, Travers JB, Rohan CA (2023) Rosacea pathogenesis and therapeutics: current treatments and a look at future targets. Front Med (Lausanne) 10:1292722

Article  PubMed  Google Scholar 

Gerber PA, Buhren BA, Steinhoff M, Homey B (2011) Rosacea: the cytokine and chemokine network. J Investig Dermatol Symp Proc 15:40–47

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gether L, Overgaard LK, Egeberg A, Thyssen JP (2018) Incidence and prevalence of rosacea: a systematic review and meta-analysis. Br J Dermatol 179:282–289

CAS  PubMed  Google Scholar 

Gouin O, Lherondelle K, Lebonvallet N, Le Gall-Ianotto C, Sakka M, Buhé V, Plée-Gautier E, Carré JL, Lefeuvre L, Misery L, Le Garrec R (2017) TRPV1 and TRPA1 in cutaneous neurogenic and chronic inflammation: pro-inflammatory response induced by their activation and their sensitization. Protein Cell 8:644–661

Article  CAS  PubMed  PubMed Central  Google Scholar 

Haber R, el Gemayel M (2018) Comorbidities in rosacea: a systematic review and update. J Am Acad Dermatol 78:786-792.e8

Article  PubMed  Google Scholar 

Holmes AD, Steinhoff M (2017) Integrative concepts of rosacea pathophysiology, clinical presentation and new therapeutics. Exp Dermatol 26:659–667

Article  CAS  PubMed  Google Scholar 

Jia T, Che D, Zheng Y, Zhang H, Li Y, Zhou T, Peng B, Du X, Zhu L, An J, Geng S (2024) Mast cells initiate type 2 inflammation through tryptase released by MRGPRX2/MRGPRB2 activation in atopic dermatitis. J Invest Dermatol 144:53-62.e2

Article  CAS  PubMed  Google Scholar 

Kamal N, Mio Asni NS, Rozlan INA, Mohd Azmi, MAH, Mazlan, NW, Mediani A, Baharum SN, Latip J, Assaw S, Edrada-Ebel RA 2022 Traditional medicinal uses, phytochemistry, biological properties, and health applications of Vitex sp Plants (Basel), 11.

Kim M, Kim J, Jeong SW, Jo H, Woo YR, Park HJ (2017) Inhibition of mast cell infiltration in an LL-37-induced rosacea mouse model using topical brimonidine tartrate 0.33% gel. Exp Dermatol 26:1143–1145

Article  CAS  PubMed  Google Scholar 

Kraft S, Kinet JP (2007) New developments in FcepsilonRI regulation, function and inhibition. Nat Rev Immunol 7:365–378

Article  CAS  PubMed  Google Scholar 

Kühn H, Kolkhir P, Babina M, Düll M, Frischbutter S, Fok JS, Jiao Q, Metz M, Scheffel J, Wolf K, Kremer AE, Maurer M (2021) Mas-related G protein-coupled receptor X2 and its activators in dermatologic allergies. J Allergy Clin Immunol 147:456–469

Article  PubMed  Google Scholar 

Lee H, Jung KH, Lee H, Park S, Choi W, Bae H (2015) Casticin, an active compound isolated from Vitex Fructus, ameliorates the cigarette smoke-induced acute lung inflammatory response in a murine model. Int Immunopharmacol 28:1097–1101

Article  CAS  PubMed  Google Scholar 

Li J, Yuan X, Tang Y, Wang B, Deng Z, Huang Y, Liu F, Zhao Z, Zhang Y (2020a) Hydroxychloroquine is a novel therapeutic approach for rosacea. Int Immunopharmacol 79:106178

Article  CAS  PubMed  Google Scholar 

Li X, Mei W, Huang Z, Zhang L, Zhang L, Xu B, Shi X, Xiao Y, Ma Z, Liao T, Zhang H, Wang P (2020b) Casticin suppresses monoiodoacetic acid-induced knee osteoarthritis through inhibiting HIF-1α/NLRP3 inflammasome signaling. Int Immunopharmacol 86:106745

Article  CAS  PubMed  Google Scholar 

Lim HW, Collins SAB, Resneck JS Jr, Bolognia JL, Hodge JA, Rohrer TA, Van Beek MJ, Margolis DJ, Sober AJ, Weinstock MA, Nerenz DR, Smith Begolka W, Moyano JV (2017) The burden of skin disease in the United States. J Am Acad Dermatol 76:958-972.e2

Article  PubMed  Google Scholar 

Lin S, Zhang H, Han T, Wu JZ, Rahman K, Qin LP (2007) In vivo effect of casticin on acute inflammation. Zhong Xi Yi Jie He Xue Bao 5:573–576

Article  CAS  PubMed  Google Scholar 

Liou CJ, Len WB, Wu SJ, Lin CF, Wu XL, Huang WC (2014) Casticin inhibits COX-2 and iNOS expression via suppression of NF-κB and MAPK signaling in lipopolysaccharide-stimulated mouse macrophages. J Ethnopharmacol 158:310–6

Article  CAS  PubMed  Google Scholar 

Liou CJ, Cheng CY, Yeh KW, Wu YH, Huang WC (2018) Protective effects of casticin from Vitex trifolia alleviate eosinophilic airway inflammation and oxidative stress in a murine asthma model. Front Pharmacol 9:635

Article  PubMed  PubMed Central  Google Scholar 

Mittal A, Sagi V, Gupta M, Gupta K (2019) Mast cell neural interactions in health and disease. Front Cell Neurosci 13:110

Article  CAS  PubMed  PubMed Central  Google Scholar